Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 37.7B | 29.7B | 20.9B | 20.2B |
Cost of revenue | 24.4B | 18.9B | 13.0B | 12.5B |
Gross profit | 13.3B | 10.8B | 7.9B | 7.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.4B | 3.2B | 2.7B | 2.1B |
Operating income | 5.7B | 4.4B | 2.4B | 3.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 847.2M | 695.3M | 560.3M | 445.2M |
Other income expense | — | — | — | — |
Pretax income | 5.5B | 3.9B | 2.0B | 3.0B |
Tax provision | -6.3B | 35.7M | 9.8M | 1.9M |
Net income | 11.8B | 3.9B | 2.0B | 3.0B |
Basic EPS | — | 0.3 | 0.2 | 0.2 |
Diluted EPS | — | 0.3 | 0.2 | 0.2 |
Basic average shares | — | 13.8B | 13.3B | 13.7B |
Diluted average shares | — | 13.8B | 13.3B | 13.7B |
EBITDA | 7.3B | 5.3B | 3.1B | 3.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | 12.4M | -8.4M | -4M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |